Prescription drug · NDA
Urso 250 (Ursodiol) NDC 58914-785
Ursodiol 250 mg/1 · Tablet, Film coated · Oral · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58914-785-10 | 58914078510 | 100 TABLET, FILM COATED in 1 BOTTLE (58914-785-10)Marketed from Dec 10, 1997 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Urso 250
- Generic name (nonproprietary)
- ursodiol
- Active ingredients
- Ursodiol — 250 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Allergan, Inc.NDC labeler code 58914
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020675
- Marketing start
- Listing expires
- Other FDA classes
- Bile Acids and Salts (Chemical structure)
- Identifiers
- Product ID 58914-785_06904c03-cea9-4532-8e27-7f2246be613bSPL ID 06904c03-cea9-4532-8e27-7f2246be613bSPL set ID e8fc4fc2-fe5c-4cba-b6e0-5ceaf2157a61RxCUI 858733, 858735, 858751, 858752UNII 724L30Y2QR
- Pharmacologic class
- Bile Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N458914078510followed by a unit qualifier and the quantityPackage 58914-0785-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
URSO 250 and URSO Forte (ursodiol) tablets are indicated for the treatment of patients with primary biliary cholangitis (PBC). URSO 250 and URSO Forte (ursodiol) tablets are bile acids indicated for the treatment of patients with primary biliary cholangitis. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 58914-785
- What is NDC 58914-785?
- 58914-785 is the product NDC for Urso 250 (ursodiol), Ursodiol 250 mg/1 tablet, film coated, listed with the FDA by Allergan, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Urso 250 (Ursodiol).
- What is the active ingredient?
- Ursodiol.
- Who is the labeler?
- Allergan, Inc., NDC labeler code 58914. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Urso 250?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 020675
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Urso Forteursodiol | Ursodiol 500 mg/1 | Tablet, Film coatedOral | Allergan, Inc. | 58914-790 |